Beta blockers are quickly becoming the hot new drug to combat anxiety. The medication, also known as propranolol, was approved by the U.S. Food and Drug Administration in 1967 for the treatment of ...

Imagine you're about to give a presentation to a room full of people. Your heart starts racing, your hands become sweaty and your voice begins to shake. Despite how much you've prepared, those ...

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

Beta-blockers may not reduce the risk of death or repeat heart attacks for patients with preserved heart function. Women may face higher risks from beta-blockers. Long-term use can cause side effects ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...